|
|||||
|
|
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study |
|
| Authors: | Suneel D. Kamath Aparna Kalyan Sheetal Kircher Halla Nimeiri Angela J. Fought Al Benson III Mary Mulcahy |
| Affiliation: | 1. Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA;2. Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Developmental Therapeutics Program, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA;3. Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA;4. Division of Biostatistics, Department of Preventative Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA |
| Abstract: | |
| Keywords: | Pancreatic cancer Ipilimumab Immunotherapy Gemcitabine Immune checkpoint inhibition |